JPS6043358B2 - ９α−ハロ−１８−メチル−２１−デスオキシプレドニンロンのエステル類の製造法 - Google Patents

９α−ハロ−１８−メチル−２１−デスオキシプレドニンロンのエステル類の製造法

Info

Publication number
JPS6043358B2
JPS6043358B2 JP50036524A JP3652475A JPS6043358B2 JP S6043358 B2 JPS6043358 B2 JP S6043358B2 JP 50036524 A JP50036524 A JP 50036524A JP 3652475 A JP3652475 A JP 3652475A JP S6043358 B2 JPS6043358 B2 JP S6043358B2
Authority
JP
Japan
Prior art keywords
methyl
desoxyprednisolone
chloro
valerate
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP50036524A
Other languages
English (en)
Japanese (ja)
Other versions
JPS50157353A (en]
Inventor
ビラツクス イヴアン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Plurichemie Anstalt
Original Assignee
Plurichemie Anstalt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plurichemie Anstalt filed Critical Plurichemie Anstalt
Publication of JPS50157353A publication Critical patent/JPS50157353A/ja
Publication of JPS6043358B2 publication Critical patent/JPS6043358B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
    • C07J7/0055—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP50036524A 1974-03-27 1975-03-26 ９α−ハロ−１８−メチル−２１−デスオキシプレドニンロンのエステル類の製造法 Expired JPS6043358B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PT6163774 1974-03-27
PT6163674 1974-03-27
PT61637 1974-03-27
PT61636 1975-03-10

Publications (2)

Publication Number Publication Date
JPS50157353A JPS50157353A (en]) 1975-12-19
JPS6043358B2 true JPS6043358B2 (ja) 1985-09-27

Family

ID=26653426

Family Applications (2)

Application Number Title Priority Date Filing Date
JP50036524A Expired JPS6043358B2 (ja) 1974-03-27 1975-03-26 ９α−ハロ−１８−メチル−２１−デスオキシプレドニンロンのエステル類の製造法
JP58069325A Granted JPS58189200A (ja) 1974-03-27 1983-04-21 ９α−ハロ−１６−メチルプレドニソロンのエステル類の製造法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP58069325A Granted JPS58189200A (ja) 1974-03-27 1983-04-21 ９α−ハロ−１６−メチルプレドニソロンのエステル類の製造法

Country Status (9)

Country Link
US (1) US4024131A (en])
JP (2) JPS6043358B2 (en])
AU (1) AU500060B2 (en])
CA (1) CA1065848A (en])
DE (1) DE2512915A1 (en])
HK (2) HK64679A (en])
NL (1) NL184321C (en])
PH (1) PH13537A (en])
SE (1) SE418294B (en])

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201778A (en) * 1977-11-08 1980-05-06 Schering Corporation 6-Acyloxy-1,4,6-pregnatrienes, their use as anti-inflammatory agents, methods for their manufacture, and 6-oxo-1,4-pregnadiene intermediates
EP0029924B1 (en) * 1979-11-16 1984-08-15 STEROSYNT Ltd. 6-alpha-fluoro-16-methyl-prednisolone-17,21 diesters and pharmaceutical compositions containing them
PT71309A (en) * 1980-05-27 1980-06-01 Hovione Sociedade Quimica Lda Process of selective
IL66432A0 (en) * 1981-08-04 1982-12-31 Plurichemie Anstalt Process for the preparation of steroidal esters
PT78973A (en) * 1984-07-25 1984-08-01 Joao Emerico Villax New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid
JPS62111184U (en]) * 1985-12-29 1987-07-15
JPH07116215B2 (ja) * 1989-04-19 1995-12-13 エスエス製薬株式会社 新規なステロイド化合物
EP1344526B1 (en) * 2000-12-22 2008-05-28 Nippon Shinyaku Co., Ltd. Preventives/remedies for inflammatory airway diseases
CN104558082B (zh) * 2013-10-16 2018-01-23 天津金耀集团有限公司 一种倍氯米松双丙酸酯的合成方法
CN104558083B (zh) * 2013-10-16 2018-08-31 天津金耀集团有限公司 一种倍氯米松双丙酸酯无有机溶剂的合成方法
CN111944002A (zh) * 2020-07-29 2020-11-17 河南利华制药有限公司 一种倍氯米松二丙酸酯中间体及制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1047518A (en) * 1963-06-11 1966-11-02 Glaxo Lab Ltd 17ª‡-monoesters of 11,17,21-trihydroxy steroid compounds
GB1070751A (en) * 1964-01-28 1967-06-01 Glaxo Lab Ltd 17-esters of 17-hydroxy-21-desoxy-steroids
NL6612191A (en]) * 1965-08-30 1967-03-01
US3639434A (en) * 1967-02-02 1972-02-01 Boots Pure Drug Co Ltd 17-acyloxysteroids and their manufacture
CH510655A (de) * 1967-11-17 1971-07-31 Ciba Geigy Ag Verfahren zur Herstellung neuer Halogenpregnadiene
GB1227992A (en]) * 1968-01-23 1971-04-15 Koninklijke Gist Spiritus
GB1281689A (en) * 1968-10-14 1972-07-12 Glaxo Lab Ltd Steroid 21-phosphates
BE785812A (fr) * 1971-07-05 1973-01-04 Glaxo Lab Ltd Nouveaux composes steroides

Also Published As

Publication number Publication date
JPS58189200A (ja) 1983-11-04
PH13537A (en) 1980-06-19
US4024131A (en) 1977-05-17
JPS50157353A (en]) 1975-12-19
AU500060B2 (en) 1979-05-10
SE418294B (sv) 1981-05-18
SE7503356L (en]) 1975-09-29
NL7503788A (nl) 1975-09-30
NL184321B (nl) 1989-01-16
HK64779A (en) 1979-09-21
HK64679A (en) 1979-09-21
AU7960375A (en) 1976-09-30
JPS6241680B2 (en]) 1987-09-03
CA1065848A (en) 1979-11-06
NL184321C (nl) 1989-06-16
DE2512915C2 (en]) 1987-09-10
DE2512915A1 (de) 1975-10-09

Similar Documents

Publication Publication Date Title
US3929768A (en) Steroids, processes for their manufacture and preparations containing same
US5482934A (en) Pregna-1,4-diene3,20-dione-16-17-acetal-21 esters, process for their preparation, composition, and methods for the treatment of inflammatory conditions
US4093721A (en) Pharmaceutical compositions of 6α,9α-difluoro-androst-4-ene-17β-carboxylates and derivatives thereof
US3780177A (en) 17-butyrate,21-ester derivatives of 6alpha,9alpha-difluoroprednisolone,compositions and use
CA1234564A (en) Carboxylic acid esters
US4267173A (en) Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor
IE45023B1 (en) Androstadiene-17-carboxylic acids and their esters
US4172132A (en) 1,3,5(10),6,8,14-19-Nor-pregnahexaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
US3992534A (en) Compositions and method of treating with component B of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steriods
JPS6043358B2 (ja) ９α−ハロ−１８−メチル−２１−デスオキシプレドニンロンのエステル類の製造法
US4576936A (en) 6α-Fluoro-9α-chloro-prednisolone 17,21-diesters
US4336200A (en) 17α-Acyloxy-5β-corticoids
US3984544A (en) Retinoic acid esters of steroids of the pregnane series, their use in the treatment of acne and pharmaceutical formulations useful therefor
US4318853A (en) 9β,11β-Epoxy-5β-corticoids
US5082835A (en) Novel steroid diols, pharmaceutical compositions containing them and process for preparing same
US4427591A (en) Reduced A ring-Δ9(11) -corticoids
JPS5922719B2 (ja) １６↓−メチル−９α−ハロステロイドのエステル及びエ−テル誘導体
JPS6411038B2 (en])
US4185101A (en) 1,3,5(10),6,8-19-Nor-pregnapentaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
JPS6150960B2 (en])
US4008313A (en) Novel corticoids
KR800000555B1 (ko) 스테로이드의 레티온산 에스테르의 제조방법
CA1118410A (en) 19-nor-pregnahexaenes, process for the preparation thereof, and pharmaceutical compositions containing them
US3763196A (en) 17-esters of 6alpha-9alpha-difluoro-21-desoxyprednisolone
US3415855A (en) Trichloro pregnadienes and esters thereof